Loading...
Regorafenib
India Pharmaceutical Trade Intelligence
Who Supplies Regorafenib to India from GREECE
India's regorafenib imports from GREECE total $534 across 3 shipments from 2 foreign suppliers. WIN MEDICA S.A. leads with $374 in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include VEEDA CLINICAL RESEARCH LIMITED. This corridor reflects India's pharmaceutical import demand for regorafenib — a concentrated sourcing relationship with select suppliers from GREECE.
Top foreign suppliers (GREECE) — Ranked by import value
WIN MEDICA S.A. is the leading Regorafenib supplier from GREECE to India, with import value of $374 across 2 shipments. The top 5 suppliers — WIN MEDICA S.A., WIN MEDICA PHARMACEUTICAL S.A. — collectively account for 100.0% of total import value from this origin.
Top foreign suppliers (GREECE)
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | WIN MEDICA S.A. | $374 | 2 | 70.0% |
| 2 | WIN MEDICA PHARMACEUTICAL S.A. | $160 | 1 | 30.0% |
Showing top 2 of 2 foreign suppliers · Indian Customs (DGFT) · TransData Nexus
Top Indian buyers (importing from GREECE)
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | VEEDA CLINICAL RESEARCH LIMITED | $299 | 1 | 55.9% |
| 2 | ENALTEC PHARMA RESEARCH PRIVATE LIMITED | $160 | 1 | 30.0% |
| 3 | QPS BIOSERVE INDIA PRIVATE LIMITED | $75 | 1 | 14.1% |
Import Statistics
- Import Value
- $534
- Shipments
- 3
- Foreign Suppliers
- 2
- Indian Buyers
- 3
- Avg. Shipment
- $178
Other Regorafenib Import Origins
Related Analysis
Frequently Asked Questions — Regorafenib Imports from GREECE
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
QWho are the top Regorafenib suppliers from GREECE to India?
The top Regorafenib suppliers from GREECE to India include WIN MEDICA S.A., WIN MEDICA PHARMACEUTICAL S.A.. The leading supplier is WIN MEDICA S.A. with import value of $374 USD across 2 shipments. India imported Regorafenib worth $534 USD from GREECE in total across 3 shipments.
QHow much Regorafenib does India import from GREECE?
India imported Regorafenib worth $534 USD from GREECE across 3 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
QWho are the main Indian buyers of Regorafenib from GREECE?
The main Indian buyers of Regorafenib sourced from GREECE include VEEDA CLINICAL RESEARCH LIMITED, ENALTEC PHARMA RESEARCH PRIVATE LIMITED, QPS BIOSERVE INDIA PRIVATE LIMITED. The largest buyer is VEEDA CLINICAL RESEARCH LIMITED with $299 in imports across 1 shipments.
QWhat is the total value of Regorafenib imports from GREECE to India?
The total value of Regorafenib imports from GREECE to India is $534 USD, across 3 shipments and 2 foreign suppliers. Data source: Indian Customs (DGFT).
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
SS
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: GREECE to India pharmaceutical import trade corridor identified from Indian Customs (DGFT) shipping bill records for Regorafenib.
- 2.Supplier/Buyer Matching: 2 foreign suppliers from GREECE and 3 Indian buyers identified using company name normalization across customs records.
- 3.Value Aggregation: Total import value of $534 aggregated from 3 verified shipping bill records. All values reported in FOB USD as recorded by Indian Customs.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
3 Verified Shipments
2 suppliers, 3 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists